Default company panoramic image

oncgnostics GmbH

Epigenetic biomarkers for reliable cancer diagnostics

  • Stage Product In Development
  • Industry Biotechnology
  • Location Jena, TH, Deutschland
  • Currency EUR
  • Founded February 2012
  • Employees 6
  • Website

Company Summary

oncgnostics develops – based on proprietary epigenetic biomarkers - highly reliable molecular in vitro diagnostic (IVD) tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. These tests are then either marketed directly by oncgnostics or out-licensed. Our first product - GynTect - will be launched in the middle of next year and is an IVD reliably detecting cervical (pre-) cancer.


Previous Investors

  • Default avatar
    High-Tech Gruenderfonds
    Default avatar
    Stiftung fuer Technologie, Innovation und Forschung in Thueringen (STIFT)